ArticleCancer chemotherapy and pharmacology2019

Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics.

I Kümler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.